Nicholas Zorko

14PUBLICATIONS
77CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer.

|Feb 27, 2026
Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors.

John R Lozada, Atef Ali, Christine Luo

|Oct 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.

Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai

|Aug 12, 2025
Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.

Nicholas A Zorko, Allison Makovec, Andrew Elliott

|Jul 24, 2025
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.

Melissa J Khaw, Nicholas A Zorko, Philippa R Kennedy

|Jan 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting.

John R Lozada, Andrew Elliott, Mark G Evans

Pageof 3

Frequent Collaborators

9 joint publications

Emmanuel S Antonarakis

6 joint publications

Elisabeth I Heath

5 joint publications

Justin Hwang

4 joint publications

Philippa R Kennedy